About Market Research Forecast

MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.

Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.

Business Address

Head Office

Ansec House 3 rd floor Tank Road, Yerwada, Pune, Maharashtra 411014

Contact Information

Craig Francis

Business Development Head

+1 2315155523

[email protected]

Extra Links

AboutContactsTestimonials
ServicesCareer

Subscribe

Get the latest updates and offers.

PackagingHealthcareAgricultureEnergy & PowerConsumer GoodsFood & BeveragesCOVID-19 AnalysisAerospace & DefenseChemicals & MaterialsMachinery & EquipmentInformation & TechnologyAutomotive & TransportationSemiconductor & Electronics

© 2026 PRDUA Research & Media Private Limited, All rights reserved

Privacy Policy
Terms and Conditions
FAQ
Report banner
Home
Industries
Healthcare
Pharmaceutical

report thumbnailPsoriasis Treatment Market

Psoriasis Treatment Market Unlocking Growth Opportunities: Analysis and Forecast 2025-2033

Psoriasis Treatment Market by Drug Class (TNF Inhibitors, Interleukins Inhibitors, Others), by Type (Plaque Psoriasis, Psoriatic Arthritis, Others), by Product Type (Biologics, Non-Biologics), by Route of Administration (Oral, Parenteral/Systemic, Topical), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by North America (U.S., Canada), by Europe (U.K., Germany, France, Italy, Spain, Scandinavia, Rest of Europe), by Asia Pacific (Japan, China, India, Australia & New Zealand, Rest of Asia Pacific), by Latin America (Brazil, Mexico, Rest of Latin America), by Middle East & Africa (GCC, South Africa, Rest of the Middle East & Africa) Forecast 2026-2034

Jan 24 2025

Base Year: 2025

150 Pages

Main Logo

Psoriasis Treatment Market Unlocking Growth Opportunities: Analysis and Forecast 2025-2033

Main Logo

Psoriasis Treatment Market Unlocking Growth Opportunities: Analysis and Forecast 2025-2033


Related Reports


report thumbnailU.S. Psoriasis Treatment Market

U.S. Psoriasis Treatment Market 2025 Trends and Forecasts 2033: Analyzing Growth Opportunities

report thumbnailPsoriatic Arthritis Treatment Market

Psoriatic Arthritis Treatment Market 2025-2033 Analysis: Trends, Competitor Dynamics, and Growth Opportunities

report thumbnailNorth America Psoriasis Treatment Market

North America Psoriasis Treatment Market Future-Proof Strategies: Market Trends 2025-2033

report thumbnailPsoriasis Biologics Drugs

Psoriasis Biologics Drugs Analysis Report 2025: Market to Grow by a CAGR of 5 to 2033, Driven by Government Incentives, Popularity of Virtual Assistants, and Strategic Partnerships

report thumbnailPsoriasis Treatment Drugs

Psoriasis Treatment Drugs 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

+1 2315155523

[email protected]

  • Home
  • About Us
  • Industries
    • Chemicals & Materials
    • Automotive & Transportation
    • Machinery & Equipment
    • Agriculture
    • COVID-19 Analysis
    • Energy & Power
    • Consumer Goods
    • Packaging
    • Food & Beverages
    • Semiconductor & Electronics
    • Information & Technology
    • Healthcare
    • Aerospace & Defense
  • Services
  • Contact
Main Logo
  • Home
  • About Us
  • Industries
    • Chemicals & Materials
    • Automotive & Transportation
    • Machinery & Equipment
    • Agriculture
    • COVID-19 Analysis
    • Energy & Power
    • Consumer Goods
    • Packaging
    • Food & Beverages
    • Semiconductor & Electronics
    • Information & Technology
    • Healthcare
    • Aerospace & Defense
  • Services
  • Contact
[email protected]
Get Free Sample
Hover animation image
Pre Order Enquiry Request discount

Pricing

$6850
Corporate License:
  • Sharable and Printable among all employees of your organization
  • Excel Raw data with access to full quantitative & financial market insights
  • Customization at no additional cost within the scope of the report
  • Graphs and Charts can be used during presentation
$5850
Multi User License:
  • The report will be emailed to you in PDF format.
  • Allows 1-10 employees within your organisation to access the report.
$4850
Single User License:
  • Only one user can access this report at a time
  • Users are not allowed to take a print out of the report PDF
BUY NOW

Related Reports

U.S. Psoriasis Treatment Market 2025 Trends and Forecasts 2033: Analyzing Growth Opportunities

U.S. Psoriasis Treatment Market 2025 Trends and Forecasts 2033: Analyzing Growth Opportunities

Psoriatic Arthritis Treatment Market 2025-2033 Analysis: Trends, Competitor Dynamics, and Growth Opportunities

Psoriatic Arthritis Treatment Market 2025-2033 Analysis: Trends, Competitor Dynamics, and Growth Opportunities

North America Psoriasis Treatment Market Future-Proof Strategies: Market Trends 2025-2033

North America Psoriasis Treatment Market Future-Proof Strategies: Market Trends 2025-2033

Psoriasis Biologics Drugs Analysis Report 2025: Market to Grow by a CAGR of 5 to 2033, Driven by Government Incentives, Popularity of Virtual Assistants, and Strategic Partnerships

Psoriasis Biologics Drugs Analysis Report 2025: Market to Grow by a CAGR of 5 to 2033, Driven by Government Incentives, Popularity of Virtual Assistants, and Strategic Partnerships

Psoriasis Treatment Drugs 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Psoriasis Treatment Drugs 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image

Tailored for you

  • In-depth Analysis Tailored to Specified Regions or Segments
  • Company Profiles Customized to User Preferences
  • Comprehensive Insights Focused on Specific Segments or Regions
  • Customized Evaluation of Competitive Landscape to Meet Your Needs
  • Tailored Customization to Address Other Specific Requirements
Ask for customization

The response was good, and I got what I was looking for as far as the report. Thank you for that.

quotation
avatar

Erik Perison

US TPS Business Development Manager at Thermon

As requested- presale engagement was good, your perseverance, support and prompt responses were noted. Your follow up with vm’s were much appreciated. Happy with the final report and post sales by your team.

quotation
avatar

Shankar Godavarti

Global Product, Quality & Strategy Executive- Principal Innovator at Donaldson

I have received the report already. Thanks you for your help.it has been a pleasure working with you. Thank you againg for a good quality report

quotation
avatar

Jared Wan

Analyst at Providence Strategic Partners at Petaling Jaya

Key Insights

The Psoriasis Treatment Marketsize was valued at USD 26.37 USD billion in 2023 and is projected to reach USD 47.59 USD billion by 2032, exhibiting a CAGR of 8.8 % during the forecast period. Psoriasis is a medical condition that has a complex range of management options that are focused on the process of soothing the symptoms and healing the skin. Non systems including topical corticosteroids and vitamin D derivatives are typically employed to decrease inflammation and decrease the rate of cell proliferation. If patients undergo phototherapy under the direction of a doctor, the symptoms of the disease may improve for many patients. Organic treatments such as oral medications that include methotrexate and biological agents are employed to address severe cases as they affect the entire body because they act on the immune system of the body. Both treatment types can be significantly different regarding the impact of the treatment, for example, where topical treatments mainly affect one area of the body, biologic agents have a systemic effect on the body. The treatment offered to the patient is determined by the psoriasis severity and the effect that the treatment had on the individual to avoid or minimize the side effects and ensure that the treatment is consistent and effective with the purpose of offering the best quality health services with a positive impact on the patient’s quality of life. 

Psoriasis Treatment Market Research Report - Market Overview and Key Insights

Psoriasis Treatment Market Market Size (In Million)

20.0M
15.0M
10.0M
5.0M
0
13.10 M
2023
14.00 M
2024
15.00 M
2025
16.10 M
2026
17.30 M
2027
Main Logo

Psoriasis Treatment Trends

Psoriasis Treatment Market Market Size and Forecast (2024-2030)

Psoriasis Treatment Market Company Market Share

Loading chart...
Main Logo
  • Increasing adoption of biologics and targeted therapies
  • Growing preference for oral and topical medications
  • Emphasis on personalized treatment plans

Driving Forces: What's Propelling the Psoriasis Treatment Market

  • Increasing Prevalence: Escalating incidence of psoriasis attributed to genetic susceptibility, environmental influences, unhealthy lifestyle choices, and an aging population.
  • Pharmaceutical Innovation: Advancements in drug therapy, including the development of highly effective biologics, targeted small molecules, and innovative delivery systems.
  • Enhanced Awareness and Patient Empowerment: Government initiatives, advocacy groups, and patient support organizations play a crucial role in educating individuals about psoriasis, promoting self-management strategies, and empowering patients to advocate for their care.
  • Governmental Support: Financial investments in research and clinical trials foster the development of novel and efficacious psoriasis treatments while ensuring patient access to affordable care.
  • Emergence of Personalized Medicine: Advancements in genetic testing and biomarkers enable tailored treatment approaches based on an individual's unique disease characteristics, improving treatment outcomes and reducing adverse effects.
  • Focus on Patient-Centric Care: The growing emphasis on patient-reported outcomes, shared decision-making, and telemedicine services enhance patient satisfaction, adherence to treatment, and overall health outcomes.

Challenges and Restraints in the Psoriasis Treatment Market

  • High Cost of Treatments: Biologics and other advanced therapies can be expensive, limiting accessibility for some patients.
  • Side Effects: Concerns about potential adverse effects associated with certain medications.
  • Treatment Resistance: Some patients may develop resistance to existing therapies.

Emerging Trends in Psoriasis Treatment

  • Precision Medicine: Tailoring treatments based on individual patient characteristics and genetic makeup.
  • Digital Health: Use of mobile applications and telemedicine to improve patient engagement and treatment adherence.
  • Combination Therapies: Combining different types of medications to enhance efficacy and reduce resistance.

Growth Catalysts in the Psoriasis Treatment Industry

  • Government Initiatives: Support for clinical trials and research.
  • Pharmaceutical Innovation: Continuous development of new and improved treatments.
  • Patient Education: Programs to educate patients about psoriasis and its management.

Market Segmentation: Psoriasis Treatment Analysis

Drug Class:

  • TNF Inhibitors
  • Interleukins Inhibitors
  • Others

Type:

  • Plaque Psoriasis
  • Psoriatic Arthritis
  • Others

Route of Administration:

  • Oral
  • Parenteral/Systemic
  • Topical

Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Leading Players in the Psoriasis Treatment Market

  • AbbVie Inc. (U.S.)
  • Novartis AG (Switzerland)
  • Johnson & Johnson Services, Inc. (U.S.)
  • Pfizer Inc. (U.S.)
  • LEO Pharma A/S (Denmark)
  • Merck & Co., Inc. (U.S.)
  • Amgen Inc. (U.S.)
  • Eli Lilly and Company (U.S.)
  • Evelo Biosciences, Inc. (U.S.)
  • UCB S.A. (Belgium)
  • Sun Pharmaceutical Industries Ltd. (India)

Significant Developments in the Psoriasis Treatment Sector

  • September 2022: Bristol Myers Squibb received FDA approval for Sotyktu, an oral treatment for plaque psoriasis.
  • July 2022: Health Canada accepted the New Drug Submission review for Roflumilast cream by Arcutis Biotherapeutics, Inc.
  • January 2022: UCB S.A. received market authorization for Bimzelx from the Japanese MHLW.
  • November 2021: AbbVie Inc. received EU approval for its SKYRIZI subcutaneous injection for psoriatic arthritis.

Comprehensive Coverage Psoriasis Treatment Market Report

The market report provides comprehensive coverage of the following aspects:

  • Market size and growth projections
  • Historical and forecast market data
  • Competitive landscape and market share analysis
  • Drivers, restraints, and industry trends
  • Market segmentation by drug class, type, administration route, and distribution channel
  • Company profiles of leading players
  • SWOT analysis and strategies for growth
  • Comprehensive industry analysis

Regional Insight

The report provides comprehensive insights into key regions, analyzing market size and growth prospects:

  • North America: Leading the global market due to high disease prevalence and the presence of major pharmaceutical companies.
  • Europe: Significant market due to well-established healthcare systems and a large patient population.
  • Asia-Pacific: Growing market potential driven by rising disposable incomes, increasing urbanization, and improved access to healthcare services.
  • Latin America: Emerging market with increasing awareness and expanding access to psoriasis treatments.
  • Middle East and Africa: Region with untapped potential due to improving healthcare infrastructure and increasing awareness.
Psoriasis Treatment Market Market Share by Region - Global Geographic Distribution

Psoriasis Treatment Market Regional Market Share

Loading chart...
Main Logo

Segmentation

The report provides a detailed segmentation of the market, including:

  • Drug class
  • Type (Psoriatic Arthritis)
  • Administration route
  • Distribution channel

Patent/Trademark Analysis

The report provides an analysis of patents and trademarks related to psoriasis treatments.

Geographic Coverage of Psoriasis Treatment Market

Higher Coverage
Lower Coverage
No Coverage

Psoriasis Treatment Market REPORT HIGHLIGHTS

AspectsDetails
Study Period 2020-2034
Base Year 2025
Estimated Year 2026
Forecast Period2026-2034
Historical Period2020-2025
Growth RateCAGR of 8.8% from 2020-2034
Segmentation
    • By Drug Class
      • TNF Inhibitors
      • Interleukins Inhibitors
      • Others
    • By Type
      • Plaque Psoriasis
      • Psoriatic Arthritis
      • Others
    • By Product Type
      • Biologics
      • Non-Biologics
    • By Route of Administration
      • Oral
      • Parenteral/Systemic
      • Topical
    • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
  • By Geography
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
      • Scandinavia
      • Rest of Europe
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • GCC
      • South Africa
      • Rest of the Middle East & Africa

Table of Contents

  1. 1. Introduction
    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions
  2. 2. Executive Summary
    • 2.1. Introduction
  3. 3. Market Dynamics
    • 3.1. Introduction
      • 3.2. Market Drivers
        • 3.2.1. Growing Prevalence of Psoriasis to Boost Treatment Demand
      • 3.3. Market Restrains
        • 3.3.1. High Medication Costs to Restrict Market Growth in Emerging Countries
      • 3.4. Market Trends
        • 3.4.1. Increasing Number of Hospitals and ASCs Identified as Significant Market Trend
  4. 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  5. 5. Global Psoriasis Treatment Market Analysis, Insights and Forecast, 2020-2032
    • 5.1. Market Analysis, Insights and Forecast - by Drug Class
      • 5.1.1. TNF Inhibitors
      • 5.1.2. Interleukins Inhibitors
      • 5.1.3. Others
    • 5.2. Market Analysis, Insights and Forecast - by Type
      • 5.2.1. Plaque Psoriasis
      • 5.2.2. Psoriatic Arthritis
      • 5.2.3. Others
    • 5.3. Market Analysis, Insights and Forecast - by Product Type
      • 5.3.1. Biologics
      • 5.3.2. Non-Biologics
    • 5.4. Market Analysis, Insights and Forecast - by Route of Administration
      • 5.4.1. Oral
      • 5.4.2. Parenteral/Systemic
      • 5.4.3. Topical
    • 5.5. Market Analysis, Insights and Forecast - by Distribution Channel
      • 5.5.1. Hospital Pharmacies
      • 5.5.2. Retail Pharmacies
      • 5.5.3. Online Pharmacies
    • 5.6. Market Analysis, Insights and Forecast - by Region
      • 5.6.1. North America
      • 5.6.2. Europe
      • 5.6.3. Asia Pacific
      • 5.6.4. Latin America
      • 5.6.5. Middle East & Africa
  6. 6. North America Psoriasis Treatment Market Analysis, Insights and Forecast, 2020-2032
    • 6.1. Market Analysis, Insights and Forecast - by Drug Class
      • 6.1.1. TNF Inhibitors
      • 6.1.2. Interleukins Inhibitors
      • 6.1.3. Others
    • 6.2. Market Analysis, Insights and Forecast - by Type
      • 6.2.1. Plaque Psoriasis
      • 6.2.2. Psoriatic Arthritis
      • 6.2.3. Others
    • 6.3. Market Analysis, Insights and Forecast - by Product Type
      • 6.3.1. Biologics
      • 6.3.2. Non-Biologics
    • 6.4. Market Analysis, Insights and Forecast - by Route of Administration
      • 6.4.1. Oral
      • 6.4.2. Parenteral/Systemic
      • 6.4.3. Topical
    • 6.5. Market Analysis, Insights and Forecast - by Distribution Channel
      • 6.5.1. Hospital Pharmacies
      • 6.5.2. Retail Pharmacies
      • 6.5.3. Online Pharmacies
  7. 7. Europe Psoriasis Treatment Market Analysis, Insights and Forecast, 2020-2032
    • 7.1. Market Analysis, Insights and Forecast - by Drug Class
      • 7.1.1. TNF Inhibitors
      • 7.1.2. Interleukins Inhibitors
      • 7.1.3. Others
    • 7.2. Market Analysis, Insights and Forecast - by Type
      • 7.2.1. Plaque Psoriasis
      • 7.2.2. Psoriatic Arthritis
      • 7.2.3. Others
    • 7.3. Market Analysis, Insights and Forecast - by Product Type
      • 7.3.1. Biologics
      • 7.3.2. Non-Biologics
    • 7.4. Market Analysis, Insights and Forecast - by Route of Administration
      • 7.4.1. Oral
      • 7.4.2. Parenteral/Systemic
      • 7.4.3. Topical
    • 7.5. Market Analysis, Insights and Forecast - by Distribution Channel
      • 7.5.1. Hospital Pharmacies
      • 7.5.2. Retail Pharmacies
      • 7.5.3. Online Pharmacies
  8. 8. Asia Pacific Psoriasis Treatment Market Analysis, Insights and Forecast, 2020-2032
    • 8.1. Market Analysis, Insights and Forecast - by Drug Class
      • 8.1.1. TNF Inhibitors
      • 8.1.2. Interleukins Inhibitors
      • 8.1.3. Others
    • 8.2. Market Analysis, Insights and Forecast - by Type
      • 8.2.1. Plaque Psoriasis
      • 8.2.2. Psoriatic Arthritis
      • 8.2.3. Others
    • 8.3. Market Analysis, Insights and Forecast - by Product Type
      • 8.3.1. Biologics
      • 8.3.2. Non-Biologics
    • 8.4. Market Analysis, Insights and Forecast - by Route of Administration
      • 8.4.1. Oral
      • 8.4.2. Parenteral/Systemic
      • 8.4.3. Topical
    • 8.5. Market Analysis, Insights and Forecast - by Distribution Channel
      • 8.5.1. Hospital Pharmacies
      • 8.5.2. Retail Pharmacies
      • 8.5.3. Online Pharmacies
  9. 9. Latin America Psoriasis Treatment Market Analysis, Insights and Forecast, 2020-2032
    • 9.1. Market Analysis, Insights and Forecast - by Drug Class
      • 9.1.1. TNF Inhibitors
      • 9.1.2. Interleukins Inhibitors
      • 9.1.3. Others
    • 9.2. Market Analysis, Insights and Forecast - by Type
      • 9.2.1. Plaque Psoriasis
      • 9.2.2. Psoriatic Arthritis
      • 9.2.3. Others
    • 9.3. Market Analysis, Insights and Forecast - by Product Type
      • 9.3.1. Biologics
      • 9.3.2. Non-Biologics
    • 9.4. Market Analysis, Insights and Forecast - by Route of Administration
      • 9.4.1. Oral
      • 9.4.2. Parenteral/Systemic
      • 9.4.3. Topical
    • 9.5. Market Analysis, Insights and Forecast - by Distribution Channel
      • 9.5.1. Hospital Pharmacies
      • 9.5.2. Retail Pharmacies
      • 9.5.3. Online Pharmacies
  10. 10. Middle East & Africa Psoriasis Treatment Market Analysis, Insights and Forecast, 2020-2032
    • 10.1. Market Analysis, Insights and Forecast - by Drug Class
      • 10.1.1. TNF Inhibitors
      • 10.1.2. Interleukins Inhibitors
      • 10.1.3. Others
    • 10.2. Market Analysis, Insights and Forecast - by Type
      • 10.2.1. Plaque Psoriasis
      • 10.2.2. Psoriatic Arthritis
      • 10.2.3. Others
    • 10.3. Market Analysis, Insights and Forecast - by Product Type
      • 10.3.1. Biologics
      • 10.3.2. Non-Biologics
    • 10.4. Market Analysis, Insights and Forecast - by Route of Administration
      • 10.4.1. Oral
      • 10.4.2. Parenteral/Systemic
      • 10.4.3. Topical
    • 10.5. Market Analysis, Insights and Forecast - by Distribution Channel
      • 10.5.1. Hospital Pharmacies
      • 10.5.2. Retail Pharmacies
      • 10.5.3. Online Pharmacies
  11. 11. Competitive Analysis
    • 11.1. Global Market Share Analysis 2025
      • 11.2. Company Profiles
        • 11.2.1 AbbVie Inc. (U.S.)
          • 11.2.1.1. Overview
          • 11.2.1.2. Products
          • 11.2.1.3. SWOT Analysis
          • 11.2.1.4. Recent Developments
          • 11.2.1.5. Financials (Based on Availability)
        • 11.2.2 Novartis AG (Switzerland)
          • 11.2.2.1. Overview
          • 11.2.2.2. Products
          • 11.2.2.3. SWOT Analysis
          • 11.2.2.4. Recent Developments
          • 11.2.2.5. Financials (Based on Availability)
        • 11.2.3 Johnson & Johnson Services Inc.(U.S.)
          • 11.2.3.1. Overview
          • 11.2.3.2. Products
          • 11.2.3.3. SWOT Analysis
          • 11.2.3.4. Recent Developments
          • 11.2.3.5. Financials (Based on Availability)
        • 11.2.4 Pfizer Inc. (U.S.)
          • 11.2.4.1. Overview
          • 11.2.4.2. Products
          • 11.2.4.3. SWOT Analysis
          • 11.2.4.4. Recent Developments
          • 11.2.4.5. Financials (Based on Availability)
        • 11.2.5 LEO Pharma A/S (Denmark)
          • 11.2.5.1. Overview
          • 11.2.5.2. Products
          • 11.2.5.3. SWOT Analysis
          • 11.2.5.4. Recent Developments
          • 11.2.5.5. Financials (Based on Availability)
        • 11.2.6 Merck & Co. Inc. (U.S.)
          • 11.2.6.1. Overview
          • 11.2.6.2. Products
          • 11.2.6.3. SWOT Analysis
          • 11.2.6.4. Recent Developments
          • 11.2.6.5. Financials (Based on Availability)
        • 11.2.7 Amgen Inc. (U.S.)
          • 11.2.7.1. Overview
          • 11.2.7.2. Products
          • 11.2.7.3. SWOT Analysis
          • 11.2.7.4. Recent Developments
          • 11.2.7.5. Financials (Based on Availability)
        • 11.2.8 Eli Lilly and Company (U.S.)
          • 11.2.8.1. Overview
          • 11.2.8.2. Products
          • 11.2.8.3. SWOT Analysis
          • 11.2.8.4. Recent Developments
          • 11.2.8.5. Financials (Based on Availability)
        • 11.2.9 Evelo Biosciences Inc. (U.S.)
          • 11.2.9.1. Overview
          • 11.2.9.2. Products
          • 11.2.9.3. SWOT Analysis
          • 11.2.9.4. Recent Developments
          • 11.2.9.5. Financials (Based on Availability)
        • 11.2.10 UCB S.A. (Belgium)
          • 11.2.10.1. Overview
          • 11.2.10.2. Products
          • 11.2.10.3. SWOT Analysis
          • 11.2.10.4. Recent Developments
          • 11.2.10.5. Financials (Based on Availability)
        • 11.2.11 Sun Pharmaceutical Industries Ltd. (India)
          • 11.2.11.1. Overview
          • 11.2.11.2. Products
          • 11.2.11.3. SWOT Analysis
          • 11.2.11.4. Recent Developments
          • 11.2.11.5. Financials (Based on Availability)

List of Figures

  1. Figure 1: Global Psoriasis Treatment Market Revenue Breakdown (USD billion, %) by Region 2025 & 2033
  2. Figure 2: North America Psoriasis Treatment Market Revenue (USD billion), by Drug Class 2025 & 2033
  3. Figure 3: North America Psoriasis Treatment Market Revenue Share (%), by Drug Class 2025 & 2033
  4. Figure 4: North America Psoriasis Treatment Market Revenue (USD billion), by Type 2025 & 2033
  5. Figure 5: North America Psoriasis Treatment Market Revenue Share (%), by Type 2025 & 2033
  6. Figure 6: North America Psoriasis Treatment Market Revenue (USD billion), by Product Type 2025 & 2033
  7. Figure 7: North America Psoriasis Treatment Market Revenue Share (%), by Product Type 2025 & 2033
  8. Figure 8: North America Psoriasis Treatment Market Revenue (USD billion), by Route of Administration 2025 & 2033
  9. Figure 9: North America Psoriasis Treatment Market Revenue Share (%), by Route of Administration 2025 & 2033
  10. Figure 10: North America Psoriasis Treatment Market Revenue (USD billion), by Distribution Channel 2025 & 2033
  11. Figure 11: North America Psoriasis Treatment Market Revenue Share (%), by Distribution Channel 2025 & 2033
  12. Figure 12: North America Psoriasis Treatment Market Revenue (USD billion), by Country 2025 & 2033
  13. Figure 13: North America Psoriasis Treatment Market Revenue Share (%), by Country 2025 & 2033
  14. Figure 14: Europe Psoriasis Treatment Market Revenue (USD billion), by Drug Class 2025 & 2033
  15. Figure 15: Europe Psoriasis Treatment Market Revenue Share (%), by Drug Class 2025 & 2033
  16. Figure 16: Europe Psoriasis Treatment Market Revenue (USD billion), by Type 2025 & 2033
  17. Figure 17: Europe Psoriasis Treatment Market Revenue Share (%), by Type 2025 & 2033
  18. Figure 18: Europe Psoriasis Treatment Market Revenue (USD billion), by Product Type 2025 & 2033
  19. Figure 19: Europe Psoriasis Treatment Market Revenue Share (%), by Product Type 2025 & 2033
  20. Figure 20: Europe Psoriasis Treatment Market Revenue (USD billion), by Route of Administration 2025 & 2033
  21. Figure 21: Europe Psoriasis Treatment Market Revenue Share (%), by Route of Administration 2025 & 2033
  22. Figure 22: Europe Psoriasis Treatment Market Revenue (USD billion), by Distribution Channel 2025 & 2033
  23. Figure 23: Europe Psoriasis Treatment Market Revenue Share (%), by Distribution Channel 2025 & 2033
  24. Figure 24: Europe Psoriasis Treatment Market Revenue (USD billion), by Country 2025 & 2033
  25. Figure 25: Europe Psoriasis Treatment Market Revenue Share (%), by Country 2025 & 2033
  26. Figure 26: Asia Pacific Psoriasis Treatment Market Revenue (USD billion), by Drug Class 2025 & 2033
  27. Figure 27: Asia Pacific Psoriasis Treatment Market Revenue Share (%), by Drug Class 2025 & 2033
  28. Figure 28: Asia Pacific Psoriasis Treatment Market Revenue (USD billion), by Type 2025 & 2033
  29. Figure 29: Asia Pacific Psoriasis Treatment Market Revenue Share (%), by Type 2025 & 2033
  30. Figure 30: Asia Pacific Psoriasis Treatment Market Revenue (USD billion), by Product Type 2025 & 2033
  31. Figure 31: Asia Pacific Psoriasis Treatment Market Revenue Share (%), by Product Type 2025 & 2033
  32. Figure 32: Asia Pacific Psoriasis Treatment Market Revenue (USD billion), by Route of Administration 2025 & 2033
  33. Figure 33: Asia Pacific Psoriasis Treatment Market Revenue Share (%), by Route of Administration 2025 & 2033
  34. Figure 34: Asia Pacific Psoriasis Treatment Market Revenue (USD billion), by Distribution Channel 2025 & 2033
  35. Figure 35: Asia Pacific Psoriasis Treatment Market Revenue Share (%), by Distribution Channel 2025 & 2033
  36. Figure 36: Asia Pacific Psoriasis Treatment Market Revenue (USD billion), by Country 2025 & 2033
  37. Figure 37: Asia Pacific Psoriasis Treatment Market Revenue Share (%), by Country 2025 & 2033
  38. Figure 38: Latin America Psoriasis Treatment Market Revenue (USD billion), by Drug Class 2025 & 2033
  39. Figure 39: Latin America Psoriasis Treatment Market Revenue Share (%), by Drug Class 2025 & 2033
  40. Figure 40: Latin America Psoriasis Treatment Market Revenue (USD billion), by Type 2025 & 2033
  41. Figure 41: Latin America Psoriasis Treatment Market Revenue Share (%), by Type 2025 & 2033
  42. Figure 42: Latin America Psoriasis Treatment Market Revenue (USD billion), by Product Type 2025 & 2033
  43. Figure 43: Latin America Psoriasis Treatment Market Revenue Share (%), by Product Type 2025 & 2033
  44. Figure 44: Latin America Psoriasis Treatment Market Revenue (USD billion), by Route of Administration 2025 & 2033
  45. Figure 45: Latin America Psoriasis Treatment Market Revenue Share (%), by Route of Administration 2025 & 2033
  46. Figure 46: Latin America Psoriasis Treatment Market Revenue (USD billion), by Distribution Channel 2025 & 2033
  47. Figure 47: Latin America Psoriasis Treatment Market Revenue Share (%), by Distribution Channel 2025 & 2033
  48. Figure 48: Latin America Psoriasis Treatment Market Revenue (USD billion), by Country 2025 & 2033
  49. Figure 49: Latin America Psoriasis Treatment Market Revenue Share (%), by Country 2025 & 2033
  50. Figure 50: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion), by Drug Class 2025 & 2033
  51. Figure 51: Middle East & Africa Psoriasis Treatment Market Revenue Share (%), by Drug Class 2025 & 2033
  52. Figure 52: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion), by Type 2025 & 2033
  53. Figure 53: Middle East & Africa Psoriasis Treatment Market Revenue Share (%), by Type 2025 & 2033
  54. Figure 54: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion), by Product Type 2025 & 2033
  55. Figure 55: Middle East & Africa Psoriasis Treatment Market Revenue Share (%), by Product Type 2025 & 2033
  56. Figure 56: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion), by Route of Administration 2025 & 2033
  57. Figure 57: Middle East & Africa Psoriasis Treatment Market Revenue Share (%), by Route of Administration 2025 & 2033
  58. Figure 58: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion), by Distribution Channel 2025 & 2033
  59. Figure 59: Middle East & Africa Psoriasis Treatment Market Revenue Share (%), by Distribution Channel 2025 & 2033
  60. Figure 60: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion), by Country 2025 & 2033
  61. Figure 61: Middle East & Africa Psoriasis Treatment Market Revenue Share (%), by Country 2025 & 2033

List of Tables

  1. Table 1: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Drug Class 2020 & 2033
  2. Table 2: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Type 2020 & 2033
  3. Table 3: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Product Type 2020 & 2033
  4. Table 4: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Route of Administration 2020 & 2033
  5. Table 5: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Distribution Channel 2020 & 2033
  6. Table 6: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Region 2020 & 2033
  7. Table 7: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Drug Class 2020 & 2033
  8. Table 8: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Type 2020 & 2033
  9. Table 9: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Product Type 2020 & 2033
  10. Table 10: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Route of Administration 2020 & 2033
  11. Table 11: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Distribution Channel 2020 & 2033
  12. Table 12: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Country 2020 & 2033
  13. Table 13: U.S. Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  14. Table 14: Canada Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  15. Table 15: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Drug Class 2020 & 2033
  16. Table 16: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Type 2020 & 2033
  17. Table 17: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Product Type 2020 & 2033
  18. Table 18: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Route of Administration 2020 & 2033
  19. Table 19: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Distribution Channel 2020 & 2033
  20. Table 20: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Country 2020 & 2033
  21. Table 21: U.K. Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  22. Table 22: Germany Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  23. Table 23: France Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  24. Table 24: Italy Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  25. Table 25: Spain Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  26. Table 26: Scandinavia Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  27. Table 27: Rest of Europe Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  28. Table 28: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Drug Class 2020 & 2033
  29. Table 29: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Type 2020 & 2033
  30. Table 30: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Product Type 2020 & 2033
  31. Table 31: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Route of Administration 2020 & 2033
  32. Table 32: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Distribution Channel 2020 & 2033
  33. Table 33: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Country 2020 & 2033
  34. Table 34: Japan Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  35. Table 35: China Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  36. Table 36: India Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  37. Table 37: Australia & New Zealand Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  38. Table 38: Rest of Asia Pacific Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  39. Table 39: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Drug Class 2020 & 2033
  40. Table 40: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Type 2020 & 2033
  41. Table 41: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Product Type 2020 & 2033
  42. Table 42: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Route of Administration 2020 & 2033
  43. Table 43: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Distribution Channel 2020 & 2033
  44. Table 44: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Country 2020 & 2033
  45. Table 45: Brazil Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  46. Table 46: Mexico Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  47. Table 47: Rest of Latin America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  48. Table 48: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Drug Class 2020 & 2033
  49. Table 49: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Type 2020 & 2033
  50. Table 50: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Product Type 2020 & 2033
  51. Table 51: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Route of Administration 2020 & 2033
  52. Table 52: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Distribution Channel 2020 & 2033
  53. Table 53: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Country 2020 & 2033
  54. Table 54: GCC Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  55. Table 55: South Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  56. Table 56: Rest of the Middle East & Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2020 & 2033

Methodology

Step 1 - Identification of Relevant Samples Size from Population Database

Step Chart
Bar Chart
Method Chart

Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Approach Chart
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.

Note*: In applicable scenarios

Step 3 - Data Sources

Primary Research

  • Web Analytics
  • Survey Reports
  • Research Institute
  • Latest Research Reports
  • Opinion Leaders

Secondary Research

  • Annual Reports
  • White Paper
  • Latest Press Release
  • Industry Association
  • Paid Database
  • Investor Presentations
Analyst Chart

Step 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.

Frequently Asked Questions

1. What is the projected Compound Annual Growth Rate (CAGR) of the Psoriasis Treatment Market?

The projected CAGR is approximately 8.8%.

2. Which companies are prominent players in the Psoriasis Treatment Market?

Key companies in the market include AbbVie Inc. (U.S.), Novartis AG (Switzerland), Johnson & Johnson Services, Inc.(U.S.), Pfizer Inc. (U.S.), LEO Pharma A/S (Denmark), Merck & Co., Inc. (U.S.), Amgen Inc. (U.S.), Eli Lilly and Company (U.S.), Evelo Biosciences, Inc. (U.S.), UCB S.A. (Belgium), Sun Pharmaceutical Industries Ltd. (India).

3. What are the main segments of the Psoriasis Treatment Market?

The market segments include Drug Class, Type, Product Type, Route of Administration, Distribution Channel.

4. Can you provide details about the market size?

The market size is estimated to be USD 26.37 USD billion as of 2022.

5. What are some drivers contributing to market growth?

Growing Prevalence of Psoriasis to Boost Treatment Demand.

6. What are the notable trends driving market growth?

Increasing Number of Hospitals and ASCs Identified as Significant Market Trend.

7. Are there any restraints impacting market growth?

High Medication Costs to Restrict Market Growth in Emerging Countries.

8. Can you provide examples of recent developments in the market?

September 2022 – Bristol Myers Squibb received the FDA approval for Sotyktu, an oral, allosteric tyrosine kinase 2-inhibitor for treating adults suffering from moderate-to-severe plaque psoriasis.

9. What pricing options are available for accessing the report?

Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4850, USD 5850, and USD 6850 respectively.

10. Is the market size provided in terms of value or volume?

The market size is provided in terms of value, measured in USD billion.

11. Are there any specific market keywords associated with the report?

Yes, the market keyword associated with the report is "Psoriasis Treatment Market," which aids in identifying and referencing the specific market segment covered.

12. How do I determine which pricing option suits my needs best?

The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

13. Are there any additional resources or data provided in the Psoriasis Treatment Market report?

While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.

14. How can I stay updated on further developments or reports in the Psoriasis Treatment Market?

To stay informed about further developments, trends, and reports in the Psoriasis Treatment Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.